REMOVAL OF ZINC IS REQUIRED FOR PROCESSING OF THE MATURE NUCLEOCAPSID PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS, TYPE-1, BY THE VIRAL PROTEASE

被引:0
|
作者
WONDRAK, EM
SAKAGUCHI, K
RICE, WG
KUN, E
KIMMEL, AR
LOUIS, JM
机构
[1] NIDDK,CELLULAR & DEV BIOL LAB,BETHESDA,MD 20892
[2] NCI,CELL BIOL LAB,BETHESDA,MD 20892
[3] NCI,FREDERICK CANC RES & DEV CTR,PROGRAM RESOURCES INC DYNCORP,ANTIVIRAL DRUG MECHANISMS LAB,FREDERICK,MD 21702
[4] SAN FRANCISCO STATE UNIV,ROMBERG TIBURON CTR,ENVIRONM TOXICOL & CHEM LAB,TIBURON,CA 94920
[5] SAN FRANCISCO STATE UNIV,ROMBERG TIBURON CTR,OCTAMER INC,TIBURON,CA 94920
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In human immunodeficiency virus, RNA selection and packaging during assembly involve the two retroviral-type fingers of the nucleocapsid protein that are held in a constrained configuration by coordinated zinc ions, In this report, we demonstrate that the nucleocapsid protein in a metal bound state is resistant to cleavage by the viral protease, but upon removal of zinc ions by chelating agents, it is hydrolyzed within the first zinc finger between Phe-16 and Asn-17. However, 3-nitrosobenzamide and cupric ions, which release zinc through oxidation of the cysteine residues of the finger, render the nucleocapsid protein resistant to cleavage. Since protease inhibitors and 3-nitrosobenzamide restrict processes relating to steps early in infection, the cleavage of the nucleocapsid protein may represent an essential event that can be exploited for the design of novel antiviral agents.
引用
收藏
页码:21948 / 21950
页数:3
相关论文
共 50 条
  • [21] DNA STRAND EXCHANGE AND SELECTIVE DNA ANNEALING PROMOTED BY THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NUCLEOCAPSID PROTEIN
    TSUCHIHASHI, Z
    BROWN, PO
    JOURNAL OF VIROLOGY, 1994, 68 (09) : 5863 - 5870
  • [22] THE CENTRAL GLOBULAR DOMAIN OF THE NUCLEOCAPSID PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS CRITICAL FOR VIRION STRUCTURE AND INFECTIVITY
    OTTMANN, M
    GABUS, C
    DARLIX, JL
    JOURNAL OF VIROLOGY, 1995, 69 (03) : 1778 - 1784
  • [23] MORPHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CHATTERJEE, S
    BASAK, S
    KHAN, NC
    PATHOBIOLOGY, 1992, 60 (04) : 181 - 186
  • [24] RADIOSENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONWAY, B
    TOMFORD, WW
    CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) : 978 - 979
  • [25] VARIANTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    TOURNIER, JN
    VERRIER, B
    BIRON, FF
    MANDRAND, B
    PEYRAMOND, D
    MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (05): : 709 - 715
  • [26] INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    PEDERSEN, C
    DANISH MEDICAL BULLETIN, 1994, 41 (01) : 12 - 22
  • [27] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE AND RIBONUCLEASE-H AS SUBSTRATES OF THE VIRAL PROTEASE
    TOMASSELLI, AG
    SARCICH, JL
    BARRETT, LJ
    REARDON, IM
    HOWE, WJ
    EVANS, DB
    SHARMA, SK
    HEINRIKSON, RL
    PROTEIN SCIENCE, 1993, 2 (12) : 2167 - 2176
  • [28] SPECIFIC BINDING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GAG POLYPROTEIN AND NUCLEOCAPSID PROTEIN TO VIRAL RNAS DETECTED BY RNA MOBILITY SHIFT ASSAYS
    BERKOWITZ, RD
    LUBAN, J
    GOFF, SP
    JOURNAL OF VIROLOGY, 1993, 67 (12) : 7190 - 7200
  • [29] VIRAL-DNA CARRIED BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIRIONS
    LORI, F
    VERONESE, FD
    DEVICO, AL
    LUSSO, P
    REITZ, MS
    GALLO, RC
    JOURNAL OF VIROLOGY, 1992, 66 (08) : 5067 - 5074
  • [30] SELECTION OF MULTIPLE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS THAT ENCODE VIRAL PROTEASES WITH DECREASED SENSITIVITY TO AN INHIBITOR OF THE VIRAL PROTEASE
    KAPLAN, AH
    MICHAEL, SF
    WEHBIE, RS
    KNIGGE, MF
    PAUL, DA
    EVERITT, L
    KEMPF, DJ
    NORBECK, DW
    ERICKSON, JW
    SWANSTROM, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (12) : 5597 - 5601